| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |